Review article: new treatments in non ‐alcoholic fatty liver disease

ConclusionsRising demand and an improved understanding of NASH pathophysiology has led to a surge in development of new therapies. Tailoring pharmacotherapy to the dominant pathogenic pathway in a given patient along with use of combination therapy is likely to represent the future direction in treatment of patients with NASH.

Source: Alimentary Pharmacology and Therapeutics - July 5, 2017 Category: Drugs & Pharmacology Authors: S. A. Townsend, P. N. Newsome Tags: REVIEW ARTICLE Source Type: research